LeMaitre Vascular, Inc. LMAT
81.52
0.70
0.87%
as of 25 Sep
- Market cap
- $1.9B
- P/E
- 28.1×
Follow LMAT
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 16.77% | 16.55% | 15.80% | 15.02% |
+8 more TTM periods Free account |
|
| 10.78% | 10.53% | 9.89% | 10.94% | ||
ROIC |
22.67% | 21.93% | 20.90% | 18.95% | |
Return on Tangible Assets |
13.46% | 13.19% | 12.58% | 11.98% | |
Average Days of Receivables |
49.63 | 50.94 | 49.15 | 49.12 | |
Free Cash Flow per Share |
3.23 | 3.47 | 3.29 | 2.92 | |
Free Cash Flow |
73.83 | 79.12 | 74.47 | 66.23 | |
Capital Expenditures |
(9.15) | (8.18) | (6.78) | (7.05) | |
Piotroski F-Score |
7.00 | 6.00 | 6.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
8.59% | 9.26% | 8.82% | 8.23% | |
Accounts Receivable Turnover |
7.27 | 7.23 | 7.84 | 7.45 | |
Accounts Payable Turnover |
17.45 | 22.25 | 26.29 | 27.34 | |
Inventory Turnover |
1.02 | 1.04 | 1.05 | 1.03 | |
Average Days of Payables |
16.61 | 21.56 | 18.73 | 18.09 | |
Days of Inventory on Hand |
361.80 | 365.27 | 361.71 | 369.52 | |
Tax Rate |
(0.22) | (0.23) | (0.23) | (0.23) | |
Research and Development Expense of Revenue |
5.87% | 5.50% | 5.66% | 5.91% | |
Selling, General and Administrative Expense of Revenue |
37.56% | 38.38% | 38.66% | 39.35% | |
Share Based Compensation of Revenue |
3.00% | 3.07% | 3.14% | 3.10% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.26 | 1.40 | 1.41 | 1.37 | |
Depreciation/Fixed assets |
0.38 | 0.40 | 0.42 | 0.41 | |
Capex/Depreciation |
(0.80) | (0.72) | (0.60) | (0.64) | |
Revenue per Share |
11.48 | 11.24 | 11.03 | 10.63 | |
Operating CF per Share |
3.63 | 3.83 | 3.59 | 3.23 | |
Capex per Share |
(0.40) | (0.36) | (0.30) | (0.31) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | |
Net Profit Margin |
25.02% | 24.35% | 23.13% | 22.14% |
Columns are period end dates